| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0025-6196(12)61011-8 |
| P698 | PubMed publication ID | 2002687 |
| P2093 | author name string | J L Diez-Martin | |
| G W Dewald | |||
| R M Petitt | |||
| D L Graham | |||
| P2860 | cites work | Proposals for the classification of the myelodysplastic syndromes | Q28275931 |
| Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia | Q34626169 | ||
| Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group | Q35013252 | ||
| Chromosome abnormalities in malignant hematologic disorders | Q39827860 | ||
| Cytogenetic studies on acute nonlymphocytic leukemias following polycythemia vera. | Q50713407 | ||
| Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Groupe Français de Cytogénétique Hématologique | Q67920392 | ||
| Unbalanced 1;7 translocation and therapy-induced hematologic disorders: a possible relationship | Q69504039 | ||
| A chromosomal profile of polycythemia vera | Q69782236 | ||
| Chromosome studies in polycythemia vera patients | Q71350008 | ||
| Karyotypic patterns and their clinical significance in polycythemia vera | Q72017030 | ||
| Deletions of chromosome 13 in malignant hematologic disorders | Q93630178 | ||
| P433 | issue | 3 | |
| P921 | main subject | polycythemia vera | Q948318 |
| P304 | page(s) | 287-299 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Chromosome studies in 104 patients with polycythemia vera | |
| P478 | volume | 66 |
| Q64988628 | A Novel Acquired t(2;4)(q36.1;q24) with a Concurrent Submicroscopic del(4)(q23q24) in An Adult with Polycythemia Vera. |
| Q42065360 | A Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis |
| Q42156726 | A case of myelodysplastic syndrome with a der(1;18)(q10;q10) translocation |
| Q81073760 | A novel chromosomal abnormality, t(6;10)(q27;q22), found in a polycythemic potential donor for allogeneic hematopoietic stem cell transplantation |
| Q31114015 | A novel t(16;20)(q22;p13) in polycythemia vera |
| Q37738434 | A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F). |
| Q45332610 | Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera |
| Q74274242 | Characterization of the breakpoints in a t(8;13)(p11;q12) translocation from a patient with myeloproliferative disease using fluorescence in situ hybridization |
| Q44560524 | Chromosomal anomalies in two coexistent myeloproliferative disorders |
| Q78825196 | Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? |
| Q43681681 | Comparative genomic hybridization in polycythemia vera and essential thrombocytosis patients |
| Q35560192 | Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes |
| Q72106206 | Deletion of the long arm of chromosome 20 in a patient with small cell lymphocytic lymphoma |
| Q48007653 | Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders |
| Q37215862 | Diagnosis of polycythaemia |
| Q38500964 | Duplication of band 12q24 in acute myeloblastic leukemia |
| Q54561738 | Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders. |
| Q78445515 | Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected |
| Q56700452 | Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera |
| Q37255024 | Genetic complexity of myeloproliferative neoplasms. |
| Q93085740 | Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019 |
| Q36680979 | Investigation of patients with polycythaemia |
| Q35790260 | JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology |
| Q73147229 | Karyotypic abnormalities in myelofibrosis following polycythemia vera |
| Q67522650 | Localization of phospholipase C-gamma 1 to mouse chromosome 2 |
| Q79079262 | Molecular cloning of a constitutional t(7;22) translocation associated with risk of hematological malignancy |
| Q35197150 | Molecular markers in myeloproliferative disorders: from classification to prognosis? |
| Q37255020 | Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs). |
| Q35560189 | Pathology of the myeloproliferative diseases |
| Q43915901 | Replication status in leukocytes of treated and untreated patients with polycythemia vera and essential thrombocytosis |
| Q37274983 | Significance of cytogenetic abnormalities in patients with polycythemia vera |
| Q53611230 | The JAK2 V617F mutation in de novo acute myelogenous leukemias. |
| Q36788138 | The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course |
| Q74290583 | Translocation (1;20)(q32;q13.3) in myelofibrosis following polycythemia vera |
Search more.